Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade-Reference-Cited by-同舟云学术

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade

Author:

Gong Jun¹,Hendifar Andrew¹,Tuli Richard²,Chuang Jeremy³,Cho May⁴,Chung Vincent⁵,Li Daneng⁵,Salgia Ravi⁶^ORCID

Affiliation:

1. Department of Gastrointestinal MalignanciesCedars‐Sinai Medical Center8700 Beverly Blvd, AC 1042C90048Los AngelesCAUSA

2. Department of Radiation OncologyCedars‐Sinai Medical Center8700 Beverly Blvd, AC 102390048Los AngelesCAUSA

3. Department of Internal MedicineHarbor‐UCLA Medical CenterBox 400, 1000 W Carson St90509TorranceCAUSA

4. Department of Internal MedicineDivision of Hematology and OncologyUC Davis Comprehensive Cancer Center4501 X Street, Ste 301695817SacramentoCAUSA

5. Department of Medical OncologyCity of Hope National Medical Center1500 E Duarte Rd, Bldg 5191010DuarteCAUSA

6. Medical Oncology and Experimental TherapeuticsCity of Hope Comprehensive Cancer CenterBuilding 51, Room 101, 1500 E Duarte St91010DuarteCAUSA

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

Reference82 articles.

5. Blockade of B7‐H1 or B7‐DC induces an anti‐tumor effect in a mouse pancreatic cancer model;Okudaira K;Int J Oncol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献